WeVote
Log In

Bill

WeVote Research Nonpartisan
Bill Summary · HB 3749

Legislative bill overview

HB 3749 establishes regulatory framework for elective intravenous (IV) therapy services in Texas, which are wellness treatments administered outside traditional medical settings. The bill defines licensing requirements, practice standards, and oversight mechanisms for providers offering IV hydration, vitamin infusions, and similar elective therapies that have grown in popularity at spas, clinics, and wellness centers.

Why is this important

Elective IV therapy has become a multimillion-dollar wellness industry with minimal regulation, creating consumer safety concerns around infection control, provider qualifications, and adverse reactions. This legislation fills a regulatory gap by establishing baseline standards before the market expands further, though it also reflects broader tension between wellness innovation and medical oversight.

Potential points of contention

  • Scope of practice disputes: Defines what constitutes "elective" IV therapy versus medical treatment, which may create gray areas between wellness practitioners and nurses/physicians regarding who can administer services
  • Licensing burden: May impose compliance costs on small wellness businesses and spas, potentially limiting service availability or increasing consumer prices
  • Consumer protection vs. market access: Balances preventing unsafe practices against allowing innovation in the growing wellness industry; some argue regulation is overdue while others contend it stifles business

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.